127
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

Deoxynivalenol suppresses circulating and splenic leukocyte subpopulations in BALB/c mice: dose response, time course and sex differences

, , , &
Pages 1070-1080 | Received 13 Oct 2008, Accepted 15 Feb 2009, Published online: 12 Jun 2009
 

Abstract

It was hypothesized that suppression of peripheral blood leukocyte subsets were markers of exposure to dietary deoxynivalenol (DON), a Fusarium graminearum mycotoxin in grain, at 1.0 mg kg−1 but not at lesser doses in BALB/c mice. Groups of 10 female and 10 male BALB/c mice were fed 0, 0.25, 0.5, 1.0, and 2.0 mg kg−1 DON for 14 and 28 days. Using flow cytometry with staining for leukocyte surface markers, the percentage of CD19+ leukocytes (B cells) in peripheral blood was decreased in both sexes of BALB/c mice after 14 days of exposure to 1.0 or 2.0 mg kg−1 DON, whereas exposure to DON over 28 days did not inhibit B cells compared to the control diet. The percentage of mononuclear cells in peripheral blood was decreased in female BALB/c mice fed 1 and 2 mg kg−1 DON after 14 days compared with control diet. The percentage of CD11b+ leukocytes (monocytes) in peripheral blood and total CD11b+ splenic leukocytes were decreased only in female mice fed 1.0 and 2.0 mg kg−1 DON after 28 days compared with control diet, which shows the greater sensitivity to DON in females compared to males. It was concluded that BALB/c mice adapted to DON exposure because peripheral blood cellular effects of DON at 14 days disappeared by 28 days with the exception of monocyte changes in females. This suggests that female sex hormones potentiate one potential marker of DON immunotoxicity in BALB/c mice.

Acknowledgements

This research was supported by a grant from US Wheat and Barley Initiative (59-0790-6-060). The authors thank Shawn M. Rigby, Cell Facility of Iowa State University for his excellent assistance with flow cytometry, and Ann Perera, W.M. Keck Metabolomics Research Laboratory.

Conflict of interest statement: The authors have no conflicts of interest with respect to this publication.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.